Joan E Herman
CIK 1248398 · President & CEO Cons and EVP · last filed 2026-10-19
Joan E Herman is a President & CEO Cons and EVP who has filed 114 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for EHC, was dated Oct 19, 2026. Across all open-market trades the lifetime net is −$11.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.1M across reported positions. 70 SEC filings were submitted jointly with Encompass Health Corp.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WLP price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2855 GAZELLE COURT
CARLSBAD, CA 92010
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EHC | Director | 49,724 | $141.03 | $7.01M | $0 | 46 | 2026-10-19 |
| IONS | Director | 51,306 | $40.15 | $2.06M | -$3.17M | 21 | 2026-07-17 |
| CONVERGYS CORP (CVG) Delisted | Director | 45,535 | — | — | $0 | 7 | 2018-05-16 |
| Encompass Health Corp (HLS) Delisted | Director | 20,981 | — | — | $35.3K | 18 | 2017-10-18 |
| Encompass Health Corp (HLS.WS) Delisted | Director | 17,511 | — | — | $0 | 5 | 2016-10-19 |
| MRV COMMUNICATIONS INC (MRVC) Delisted | Director | 2,940 | — | — | $0 | 4 | 2011-06-02 |
| Elevance Health, Inc. (WLP) Delisted | President & CEO Cons and EVP | 64,685 | — | — | -$8.78M | 11 | 2007-12-11 |
Recent Filings
114 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-19 | EHC | Grant (A) | +81 | $0 | EDGAR |
| 2026-07-17 | IONS | Exer (M) | +5,220 | $0 | EDGAR |
| 2026-07-16 | EHC | Grant (A) | +85 | $0 | EDGAR |
| 2026-07-06 | IONS | Grant (A) | — | $0 | EDGAR |
| 2026-05-11 | EHC | Grant (A) | +1,634 | $0 | EDGAR |
| 2026-04-16 | EHC | Grant (A) | +85 | $0 | EDGAR |
| 2026-01-16 | EHC | Grant (A) | +87 | $0 | EDGAR |
| 2025-11-20 | IONS | Mixed | — | -$648.4K | EDGAR |
| 2025-11-19 | IONS | Notice (144) | −44,000 | -$3.26M | EDGAR |
| 2025-10-16 | EHC | Grant (A) | +73 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.